GlaxoSmithKline and Sanofi are close to reaching a 500 million pound ($624 million) deal to supply the UK government with 60 million doses of coronavirus vaccine, the Sunday Times reported, as countries race to stock up on possible Covid-19 treatments in development.
Money would be paid in stages as the vaccine progresses, with final payment made on delivery. The deal is expected to be announced in the coming days, the newspaper said.
The UK is “engaging with a wide range of companies both in the U.K. and abroad to negotiate access to vaccines,” said a government spokeswoman by email. “Appropriate announcements of these arrangements will be made as and when agreements with any of these companies are finalized and signed.”
Coronavirus: UAE approves Gilead’s COVID-19 drug remdesivir for patient useGilead Sciences announced on Sunday that the UAE Ministry of Health and Prevention had granted regulatory approval for the coronavirus drug remdesivir ... Coronavirus
Coronavirus: EU approves anti-viral drug Remdesivir to treat COVID-19The European Commission, the bloc’s executive arm, on Friday authorized the use of anti-viral drug Remdesivir to treat the new coronavirus.For more ... Coronavirus
Coronavirus: New COVID-19 drug developed by Saudi Arabian company, US partnersA Saudi Arabian company is developing a coronavirus preventative drug set to be out next year, in collaboration with American scientists at the ... Coronavirus